Correspondence 0001104659-25-013023 from ArrowMark Financial Corp. (BANX) (CIK 0001578987) (BANX)
ArrowMark Financial Corp. (BANX) (CIK 0001578987)
Date: Feb. 13, 2025 · CIK: 0001578987 · Accession: 0001104659-25-013023
AI Filing Summary & Sentiment
File numbers found in text: 333-281004, 811-22853
Show Raw Text
CORRESP
1
filename1.htm
Troutman Pepper Locke LLP
305 Church at N. Hills Street, Suite 1200
Raleigh, NC 27609
troutman.com
James L. Severs
james.severs@troutman.com
February 13, 2025
Division of Investment Management
U.S. Securities and Exchange Commission
100 F Street, NE
Washington, D.C. 20549
Attn: Karen Rossotto, Senior Counsel
Re: ArrowMark
Financial Corp. (the “Company”)
Registration Statement on Form N-2
1940 Act File No. 811-22853
1933 Act File No. 333-281004
Mses. Fettig and Rossotto:
This letter responds to the supplemental comments
of the staff of the Commission (the “Staff”) to Pre-Effective Amendment No. 2 to the Company’s Registration Statement
on Form N-2 (the “Pre-Effective Amendment”) provided on February 11, 2025 by Karen L. Rossotto. The Pre-Effective
Amendment was filed on February 7, 2025 under the Securities Act of 1933, as amended (the “1933 Act”), and under the
Investment Company Act of 1940, as amended (the “1940 Act”). The Registration Statement relates to the registration, under
the 1933 Act, of the proposed offerings from time to time by the Company of up to an aggregate of $150,000,000 of the Company’s
common stock, preferred stock, debt securities, or subscription rights to purchase shares of common stock.
We appreciate the opportunity to address the
Staff’s comments regarding certain disclosure in the Registration Statement. We have organized this letter by setting forth the
Staff’s comments in italics followed by the Company’s response to the Staff’s comments.
Supplemental Comments
1. Please confirm that all types of instruments in which the
Company may invest as part of its principal investment strategy are disclosed in the Prospectus
Summary.
Response: The Company so confirms.
Karen Rossotto
February 13, 2025
Page 2
2. Please refer to “below investment grade securities”
consistently as such rather than as non-investment grade securities.
Response: The Company has revised all references
to non-investment grade securities to refer to such securities as “below investment grade securities.”
3. Please confirm that the statistics related to the community
banking sector included under “Banking Sector Focus” are the most recent such
statistics available to the Company.
Response: The Company so confirms.
4. The staff notes that the disclosure appears to disclose
in some instances that the Company will invest in convertible securities while, in instances,
referring to contingent convertible securities. Please revise the disclosure to clarify whether
the Company may invest in contingent convertible securities, convertible securities, or both
as part of its principal investment strategy.
Response: The Company has revised the disclosure
to clarify that it may invest in convertible securities, including contingent convertible securities. The Company notes that the risk
disclosure with respect to convertible securities addresses the risks of both convertible securities generally and contingent convertible
securities specifically.
5. Please revise the disclosure included in the last sentence
under “Market Opportunity” to clarify the meaning of “other regulated banking
institutions.”
Response: The Company has revised the disclosure
to clarify that, along with community banks, it may invest in larger U.S. banks and global money center banks.
Karen Rossotto
February 13, 2025
Page 3
6. The Staff notes that the disclosure appearing under “Additional
Risks Related to Investments in CLOs” stats that the Company is subject to risks associated
with the bankruptcy or insolvency of an issuer or borrower of a loan that it holds. Please
confirm whether the Company intends to invest in loans as part of its principal investment
strategy and, if so, include appropriate disclosure in the Prospectus Summary and Risk Factors
sections.
Response: The reference to loans in the above
referenced risk disclosure related to loans underlying CLOs in which the Company may invest. The Company has revised this disclosure
to clarify that it is subject to risks associated with the bankruptcy or insolvency of an issuer or borrower of a loan underlying
a Structured Product that it holds.
* * *
Please direct any questions
concerning this letter to my attention at 919.835.4142, or in my absence to John P. Falco of this office at 215.981.4659.
Very truly yours,
/s/ James L. Severs
James L. Severs
cc:
Sanjai Bhonsle, Chairman and Chief
Executive Officer
Patrick Farrell, Chief Financial Officer
Rick Grove, Chief Compliance Officer
John P. Falco, Esq.
Theodore D. Edwards, Esq.